Survey: COVID-19 Vaccines on Developed and Developing Countries

World Health Organization director-general Tedros Adhanom Ghebreyesus warns everyone about the inequitable distribution of COVID-19 vaccines between rich and poor countries. This is after realizing that richer countries are buying up and hoarding all the available vaccines, leaving none for the poorer countries.

Meanwhile, Pfizer announced this January 2021 that it will provide up to 40 million of its COVID-19 vaccine doses to poorer countries on a non-profit basis, through the globally-pooled Covax facility. Since dozens of the world’s richer countries have already begun their vaccination campaigns to end the pandemic, it is the opposite for poor countries.

Developing countries should have “the same access to vaccines as the rest of the world”, said Pfizer chairman Albert Bourla at a virtual press conference. He also said,

“We are proud to have this opportunity to provide doses that will support Covax’s efforts towards vaccinating health care workers at high risk of exposure in developing countries, and other vulnerable populations.”

In line with this, Real Research created this survey to know if people think there should be fair and equal access to COVID-19 vaccines in every country. Also, if they do agree that developed countries will be able to vaccinate before many developing countries? In their opinion, can COVID-19 vaccines reach both privileged and less privileged overtime?

Share your opinion by answering this survey! Answer on the Real Research Survey App from 9 March 2021. In return, 10 TNC Coins will be given as rewards for your survey participation.